ower to institute policies which restrict the use of specialty drugs and only giving priority to those who are in need. Increased efforts are also being instituted so as to provide research on the possible benefits and costs of specialty drugs with reports being expected on the newly approved high impact drugs. The reports will be responsible for the analysis of the drug’s effectiveness and the potential economic burden.
Specialty Drug Policy Making
Several policies are which are aimed at maximizing the treatment adherence are being instituted or moderated on by the policymakers. This had mainly been brought about by the notion that specialty drugs result in healthcare funding waste with the high costs going to waste when patients have poor …show more content…
This is because politics plays a major role in the process of policy making (Birkland 2011, p. 7). As much as health plans efforts are required to help in the improvement of access to specialty drugs while reducing the growth of the spending, substantial policies and reforms are still required at all the levels of the government. This is to promote patient safety and encourage market competition at the same time which is advantageous to the consumers. Most of these policies “consists of research and the implementation of public policy usually limited to the American context, emphasizing national and domestic policy” and that the policy must “have a cultural definition of policy problems, policy formulation, policy feasibility and policy implementation” (Birkland, 2011, p. …show more content…
Such a structure would ensure the access to the new drugs with new value evidence being generated by the patients and, therefore, being able to quantify the value for their money. On the same note, alternative arrangements including outcome-based contracting, reimbursement of providers with a flat fee for producing the drugs would be effective in the provision of financial incentives for the manufacturers of the new drugs and pharmaceutical technologies which is very critical for improving the standards of quality care, performance, and good health outcomes. The effective application of comparative data is also key in the improvement of the growth of innovative payment
Specialty Drug Policy Making
Several policies are which are aimed at maximizing the treatment adherence are being instituted or moderated on by the policymakers. This had mainly been brought about by the notion that specialty drugs result in healthcare funding waste with the high costs going to waste when patients have poor …show more content…
This is because politics plays a major role in the process of policy making (Birkland 2011, p. 7). As much as health plans efforts are required to help in the improvement of access to specialty drugs while reducing the growth of the spending, substantial policies and reforms are still required at all the levels of the government. This is to promote patient safety and encourage market competition at the same time which is advantageous to the consumers. Most of these policies “consists of research and the implementation of public policy usually limited to the American context, emphasizing national and domestic policy” and that the policy must “have a cultural definition of policy problems, policy formulation, policy feasibility and policy implementation” (Birkland, 2011, p. …show more content…
Such a structure would ensure the access to the new drugs with new value evidence being generated by the patients and, therefore, being able to quantify the value for their money. On the same note, alternative arrangements including outcome-based contracting, reimbursement of providers with a flat fee for producing the drugs would be effective in the provision of financial incentives for the manufacturers of the new drugs and pharmaceutical technologies which is very critical for improving the standards of quality care, performance, and good health outcomes. The effective application of comparative data is also key in the improvement of the growth of innovative payment